[Gene amplification to detect herpes simplex virus (HSV) and varicella-zoster virus (VZV) genomes in cerebrospinal fluid in cases of encephalitis]
Haute Autorité de Santé
Record ID 32016000222
French
Authors' objectives:
The aim of this report is to analyse coherence between the application, and good professional practice guidelines and professional opinion, with a view to including gene amplification for detecting herpes simplex and varicella-zoster virus genomes in cerebrospinal fluid (CSF) in patients with encephalitis on the list of clinical laboratory procedures reimbursed by the National Health Insurance system in France.
Authors' recommendations:
As there is consistency between the application and the conclusions of the guidelines identified and analysed, along with the opinions of professional organisations, HAS recommends inclusion of gene amplification to detect herpes simplex and varicellazoster virus genomes in CSF in patients with suspected infectious encephalitis on the list of procedures reimbursed by the National Health Insurance system.
Details
Project Status:
Completed
Year Published:
2015
URL for published report:
http://www.has-sante.fr/portail/upload/docs/application/pdf/2015-06/argumentaire_hsv_vzv_vd_2015-06-29_12-06-3_178.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
France
MeSH Terms
- Humans
- Encephalitis
- Gene Amplification
- Herpes Simplex
- Herpes Zoster
- Herpesvirus 3, Human
- Simplexvirus
Contact
Organisation Name:
Haute Autorité de Santé
Contact Address:
2 avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France. Tel: +33 01 55 93 71 88; Fax: +33 01 55 93 74 35;
Contact Name:
has.seap.secretariat@has-sante.fr
Contact Email:
has.seap.secretariat@has-sante.fr
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.